acr-033 Search Results


cmklr1  (Alomone Labs)
91
Alomone Labs cmklr1
Identification of DEGs and functional enrichment analysis. A. Volcano plots depicting DEGs in atrial tissue datasets GSE159612 , GSE128188 , and GSE79768 . B. Venn diagram illustrating overlapping DEGs shared between obesity-related and AF-related datasets. C. GO and KEGG pathway enrichment analysis of the common DEGs. D. PPI network constructed from the common DEGs. E. <t>CMKLR1</t> mRNA expression levels in datasets GSE159612 , GSE128188 , and GSE79768 (comparisons of AF vs. SR or obese vs. normal-weight groups, as indicated). F. Representative immunofluorescence images showing CMKLR1 protein expression and subcellular localization in atrial cardiomyocytes from LFD and HFD mice ( n = 3). G. Densitometric quantification of CMKLR1 protein expression in atrial cardiomyocytes from LFD and HFD groups ( n = 3). AF, atrial fibrillation; SR, sinus rhythm; DEGs, differentially expressed genes; GO, gene ontology; KEGG, Kyoto encyclopedia of genes and genomes; PPI, protein-protein interaction; LFD, low-fat diet; HFD, high-fat diet. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. LFD group.
Cmklr1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acr-033/Anti-Rat+CMKLR1+Antibody/pmc12773632-188-25-31
Average 91 stars, based on 1 article reviews
cmklr1 - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

Image Search Results


Identification of DEGs and functional enrichment analysis. A. Volcano plots depicting DEGs in atrial tissue datasets GSE159612 , GSE128188 , and GSE79768 . B. Venn diagram illustrating overlapping DEGs shared between obesity-related and AF-related datasets. C. GO and KEGG pathway enrichment analysis of the common DEGs. D. PPI network constructed from the common DEGs. E. CMKLR1 mRNA expression levels in datasets GSE159612 , GSE128188 , and GSE79768 (comparisons of AF vs. SR or obese vs. normal-weight groups, as indicated). F. Representative immunofluorescence images showing CMKLR1 protein expression and subcellular localization in atrial cardiomyocytes from LFD and HFD mice ( n = 3). G. Densitometric quantification of CMKLR1 protein expression in atrial cardiomyocytes from LFD and HFD groups ( n = 3). AF, atrial fibrillation; SR, sinus rhythm; DEGs, differentially expressed genes; GO, gene ontology; KEGG, Kyoto encyclopedia of genes and genomes; PPI, protein-protein interaction; LFD, low-fat diet; HFD, high-fat diet. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. LFD group.

Journal: Channels

Article Title: Association of the chemerin-CMKLR1 with atrial potassium current dysregulation and atrial fibrillation in obese mice

doi: 10.1080/19336950.2025.2611704

Figure Lengend Snippet: Identification of DEGs and functional enrichment analysis. A. Volcano plots depicting DEGs in atrial tissue datasets GSE159612 , GSE128188 , and GSE79768 . B. Venn diagram illustrating overlapping DEGs shared between obesity-related and AF-related datasets. C. GO and KEGG pathway enrichment analysis of the common DEGs. D. PPI network constructed from the common DEGs. E. CMKLR1 mRNA expression levels in datasets GSE159612 , GSE128188 , and GSE79768 (comparisons of AF vs. SR or obese vs. normal-weight groups, as indicated). F. Representative immunofluorescence images showing CMKLR1 protein expression and subcellular localization in atrial cardiomyocytes from LFD and HFD mice ( n = 3). G. Densitometric quantification of CMKLR1 protein expression in atrial cardiomyocytes from LFD and HFD groups ( n = 3). AF, atrial fibrillation; SR, sinus rhythm; DEGs, differentially expressed genes; GO, gene ontology; KEGG, Kyoto encyclopedia of genes and genomes; PPI, protein-protein interaction; LFD, low-fat diet; HFD, high-fat diet. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. LFD group.

Article Snippet: Primary antibodies diluted in blocking buffer were applied overnight at 4°C as follows: resistin (1:1,000; Abcam, USA), chemerin (1:1,000; Abcam, USA), leptin (1:1,000; Abcam, USA), CMKLR1 (1:1,000; InvitrogenTM, USA), Kv4.3 (1:1,000; Alomone Labs, Israel), Kv4.2 (1:1,000; Alomone Labs, Israel), KChIP2 (1:1,000; Alomone Labs, Israel), Kv1.5 (1:1,000; Alomone Labs, Israel), Kir2.1 (1:1,000; Alomone Labs, Israel), β-Tubulin (1:1,000; Abcam, USA).

Techniques: Functional Assay, Construct, Expressing, Immunofluorescence